Susteren, Netherlands 7/13/15—Research reagent firm Nordic-MUbio has acquired the antibody and protein assets of US-based Brighter Ideas for an undisclosed amount. The acquisition includes the only source of antibodies against native Aequorea victoria green fluorescent protein (GFP). “Citations of GFP remain at a very high level since it was first described in 1994 as it is used extensively in a number of applications,” stated Nordic-MUbio CEO Ronald Rutten. Nordic-MUbio stated that it will offer quicker and more flexible service to Brighter’s bulk customers.